- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/645 - Secretins
Patent holdings for IPC class C07K 14/645
Total number of patents in this class: 52
10-year publication summary
|
3
|
5
|
4
|
7
|
7
|
2
|
5
|
4
|
10
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Eli Lilly and Company | 3834 |
7 |
| Novo Nordisk A/S | 2284 |
4 |
| Antag Therapeutics ApS | 12 |
4 |
| Adda Biotech Inc. | 6 |
3 |
| Sunshine Lake Pharma Co., Ltd. | 597 |
3 |
| Shattuck Labs, Inc. | 120 |
3 |
| Hanmi Pharm. Co., Ltd. | 571 |
2 |
| The United States Government AS represented by The Department of Veterans Affairs | 1166 |
2 |
| University of Copenhagen | 412 |
2 |
| Zealand Pharma A/S | 252 |
2 |
| Hangzhou Zhongmeihuadong Pharmaceutical Co. Ltd. | 77 |
2 |
| The Board of Trustees of the Leland Stanford Junior University | 6402 |
1 |
| The Trustees of Columbia University in the City of New York | 3566 |
1 |
| Bolder Biotechnology, Inc. | 15 |
1 |
| CEM Corporation | 102 |
1 |
| Eiger BioPharmaceuticals, Inc. | 33 |
1 |
| Han, Jie | 14 |
1 |
| Indiana University Research and Technology Corporation | 798 |
1 |
| Innovation Ulster Limited | 16 |
1 |
| Jiangnan University | 1524 |
1 |
| Other owners | 9 |